The main biologically significant molecular markers of human tumors are discussed on the basis of modern published data and author’s findings of many-year studies: steroid hormone receptors, growth factors and underlying signal proteins, tumor-associated proteases, and angiogenesis markers. Methodological aspects, progress in preclinical studies, international recommendations on the use of these parameters for prediction of the disease course and prescription of effective therapy are analyzed. Latest data on the potentialities and limitations of modern highly productive technologies (microchips) as an alternative to studies of individual molecular markers are presented.
Similar content being viewed by others
References
E. S. Gershtein, L. A. Androsova, V. P. Letyagin, and N. E. Kushlinsky, Vestn. Rossiisk. Onkol. Tsentra, No. 1, 27–33 (2000).
E. S. Gershtein, L. B. Bocharova, V. D. Ermilova, et al., Vopr. Onkol., 46, No. 2, 180–186 (2000).
E. S. Gershtein, E. V. Gritsaenko, M. E. Shcherbakov, et al., Ibid., 49, No. 6, 725–729 (2003).
E. S. Gershtein, E. A. Korotkova, V. V. Prorokov, et al., Byull. Eksp. Biol. Med., 145, No. 3, 337–341 (2008).
E. S. Gershtein, E. A. Korotkova, A. M. Shcherbakov, et al., Ibid., 143, No. 4, 438–441 (2007).
E. S. Gershtein and N. E. Kushlinsky, Klin. Lab. Diagnost., No. 1, 9–12 (1996).
E. S. Gershtein and N. E. Kushlinsky, Practical Oncology: Selected Lectures, Eds. S. A. Tyulyandin and V. M. Moiseenko [in Russian], St. Petersburg (2004), P. 41–50.
E. S. Gershtein and N. E. Kushlinsky, Vopr. Biol., Med. Farm. Khim., No. 1, 4–9 (2007).
E. S. Gershtein, M. A. Muaviya, N. E. Kushlinsky, and V. P. Letyagin, Vopr. Onkol., 44, No. 4, 383–389 (1998).
E. S. Gershtein, Sh. Zh. Talaeva, M. N. Sandybaev, and N. E. Kushlinsky, Mol. Med., No. 1, 4–8 (2007).
E. S. Gershtein, V. A. Shatskaya, K. K. Laktionov, et al., Byull. Eksp. Biol. Med., 130, No. 12, 648–650 (2000).
E. S. Gershtein, A. M. Shcherbakov, S. K. Alieva, et al., Ibid., 135, No. 1, 99–102 (2003).
E. S. Gershtein, A. M. Shcherbakov, D. Yu. Goncharov, et al., Vopr. Biol., Med. Farm. Khim., No. 1, 26–29 (2004).
E. A. Kim, E. S. Gershtein, I. V. Vysotskaya, and N. E. Kushlinsky, Byull. Eksp. Biol. Med., 145, No. 2, 206–209 (2008).
E. A. Kim, E. S. Gershtein, A. M. Shcherbakov, et al., Vopr. Onkol., 54, No. 3, 287–293 (2008).
O. I. Kostyleva, A. Yu. Dykhno, E. S. Gershtein, et al., Byull. Eksp. Biol. Med., 127, No. 4, 446–449 (1999).
O. I. Kostyleva, A. A. Radchenko, E. S. Gershtein, et al., Vopr. Biol., Med. Farm. Khim., No. 1, 30–34 (1998).
N. E. Kushlinsky and E. S. Gershtein, Byull. Eksp. Biol. Med., 126, No. 11, 485–496 (1998).
N. E. Kushlinsky and E. S. Gershtein, Ibid., 133, No. 6, 604–612 (2002).
N. E. Kushlinsky, M. F. Trapeznikova, P. A. Glybin, et al., Ibid., 145, No. 6, 691–694 (2008).
N. E. Kushlinsky, V. P. Shirokii, E. S. Gershtein, et al., Ibid., 143, No. 4, 427–430 (2007).
Steroid Hormone Receptors in Human Tumors, Ed. L. S. Bassalyk [in Russian], Moscow (1987).
A. M. Shcherbakov, E. S. Gershtein, O. A. Anurova, and N. E. Kushlinsky, Byull. Eksp. Biol. Med., 139, No. 5, 570–572 (2005).
A. M. Shcherbakov, E. S. Gershtein, O. A. Anurova, and N. E. Kushlinsky, Vopr. Onkol., 51, No. 3, 317–321 (2005).
M. De Laurentiis, G. Cancello, L. Zinno, et al., Ann. Oncol., 16, Suppl. 4, iv7-iv13 (2005).
M. J. Duffy, Ann. Clin. Biochem., 41, Pt. 5, 370–377 (2004).
M. J. Duffy, Clin. Chem., 51, No. 3, 494–503 (2005).
M. J. Duffy and C. Duggan, Clin. Biochem., 37, No. 7, 541–548 (2004).
C. Fan, D. S. Oh, L. Wessels, et al. N. Engl. J. Med., 355, No. 6, 560–569 (2006).
N. Ferrara, H. P. Gerber, and J. LeCouter, Nat. Med., 9, No. 6, 669–676 (2003).
E. S. Gershtein, E. A. Korotkova, V. V. Prorokov, et al., Tumor Biology, 29, Suppl. 1, 63 (2008).
E. S. Gershtein, A. M. Shcherbakov, O. A. Anurova, et al., Int. J. Biol. Markers, 21, No. 1, 12–19 (2006).
E. S. Gershtein, A. M. Shcherbakov, V. A. Shatskaya, et al., Anticancer Res., 27, No. 4A, 1777–1782 (2007).
E. S. Gershtein, V. A. Shatskaya, V. D. Ermilova, et al., Clin. Chim. Acta, 287, Nos. 1–2, 59–67 (1999).
A. Goldhirsch, J. H. Glick, R. D. Gelber, et al., Ann. Oncol., 16, No. 10, 1569–1583 (2005).
P. M. Harari, Endocr. Relat. Cancer, 11, No. 4, 689–708 (2004).
J. P. Ioannidis, Nat. Clin. Pract. Oncol., 3, No. 10, 538–539 (2006).
F. Janicke, A. Prechtl, C. Thomssen, et al., J. Natl. Cancer Inst., 93, No. 12, 913–920 (2001).
C. J. Langer, Int. J. Radiat. Oncol. Biol. Phys., 58, No. 3, 991–1002 (2004).
L. F. Li, X. J. Xu, Y. Zhao, et al., Breast Cancer Res. Treat., 113, No. 2, 231–237 (2009).
M. P. Look, W. L. van Putten, M. J. Duffy, et al., J. Natl. Cancer Inst., 94, No. 2, 116–128 (2002).
D. Luftner, C. Luke, and K. Possinger, Clin. Biochem., 36, No. 4, 233–240 (2003).
L. Marchionni, R. F. Wilson, A. C. Wolff, et al., Ann. Intern. Med., 148, No. 5, 358–369 (2008).
O. Modlich, H. B. Prisack, and H. Bojar, Expert Opin. Pharmacother., 7, No. 15, 2069–2078 (2006).
N. Moghal and P. W. Sternberg, Curr. Opin. Cell Biol., 11, No. 2, 190–196 (1999).
M. M. Persing, D. Paepke, M. Schmidt, et al., J. Clin. Oncol., 25, No. 18S, Suppl., 11,081 (2007).
G. L. Plosker and S. J. Keam, Drugs, 66, No. 4, 449–475 (2006).
L. Pusztai, C. Mazouni, K. Anderson, et al., Oncologist, 11, No. 8, 868–877 (2006).
Recommendations from the EGAPP Working Group: Can Tumor Gene Expression Profiling Improve Outcomes in Patients with Breast Cancer?, Genet. Med., 11, No. 1, 66–73 (2009).
J. S. Reis-Filho, C. Westbury, and J. Y. Pierga, J. Clin. Pathol., 59, No. 3, 225–231 (2006).
R. Rosell, M. Taron, N. Reguart, et al., Clin. Cancer Res., 12, No. 24, 7222–7231 (2006).
J. S. Ross, C. Hatzis, W. F. Symmans, et al., Oncologist, 13, No. 5, 477–493 (2008).
D. H. Roukos, E. Parakevaidis, and A. M. Kappas, Ann. Surg. Oncol., 13, No. 3, 433–435 (2006).
L. Ryden, M. Stendahl, H. Jonsson, et al., Breast Cancer Res. Treat., 89, No. 2, 135–143 (2005).
J. Tol, M. Koopman, A. Cats, et al., N. Engl. J. Med., 360, No. 6, 563–572 (2009).
M. J. van de Vijver, Y. D. He, L. J. van’t Veer, et al., Ibid., 347, No. 25, 1999–2009 (2002).
N. van Zandwijk, A. Mathy, L. Boerrigter, et al., Ann. Oncol., 18, No. 1, 99–103 (2007).
Author information
Authors and Affiliations
Corresponding author
Additional information
Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 148, No. 8, pp. 199–208, August, 2009
Rights and permissions
About this article
Cite this article
Kushlinsky, N.E., Gershtein, E.S., Ovchinnikova, L.K. et al. Molecular Markers of Tumors. Bull Exp Biol Med 148, 230 (2009). https://doi.org/10.1007/s10517-009-0661-5
Received:
Published:
DOI: https://doi.org/10.1007/s10517-009-0661-5